161 related articles for article (PubMed ID: 11697326)
1. Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice.
Greer S; Alvarez M; Mas M; Wozniak C; Arnold D; Knapinska A; Norris C; Burk R; Aller A; Dauphinée M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):791-806. PubMed ID: 11697326
[TBL] [Abstract][Full Text] [Related]
2. Radiation, pool size and incorporation studies in mice with 5-chloro-2'-deoxycytidine.
Santos O; Perez LM; Briggle TV; Boothman DA; Greer SB
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):357-65. PubMed ID: 2394614
[TBL] [Abstract][Full Text] [Related]
3. Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation.
Greer S; Schwade J; Marion HS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1059-69. PubMed ID: 7607927
[TBL] [Abstract][Full Text] [Related]
4. Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
Perez LM; Mekras JA; Briggle TV; Greer S
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1453-8. PubMed ID: 6236189
[TBL] [Abstract][Full Text] [Related]
5. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice.
Greer S; Santos O; Gottlieb C; Schwade J; Marion HS
Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.
Greer S; Han T; Dieguez C; McLean N; Saer R; Reis I; Levi J; Marquez VE
Anticancer Agents Med Chem; 2017; 17(2):250-264. PubMed ID: 27745548
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
Perez LM; Greer S
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1523-7. PubMed ID: 3759575
[TBL] [Abstract][Full Text] [Related]
8. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Perez LM; Greer S
Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
[TBL] [Abstract][Full Text] [Related]
9. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
[TBL] [Abstract][Full Text] [Related]
10. 5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice.
Santos O; Pant KD; Blank EW; Ceriani RL
J Nucl Med; 1992 Aug; 33(8):1530-4. PubMed ID: 1634946
[TBL] [Abstract][Full Text] [Related]
11. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture.
Boothman DA; Briggle TV; Greer S
Mol Pharmacol; 1985 May; 27(5):584-94. PubMed ID: 2581125
[TBL] [Abstract][Full Text] [Related]
12. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Greer SB
Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
[TBL] [Abstract][Full Text] [Related]
13. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
14. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model.
Joschko MA; Webster LK; Groves J; Yuen K; Palatsides M; Ball DL; Millward MJ
Radiat Oncol Investig; 1997; 5(2):62-71. PubMed ID: 9303059
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
[TBL] [Abstract][Full Text] [Related]
17. Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
Lawrence TS; Davis MA
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1243-6. PubMed ID: 2715074
[TBL] [Abstract][Full Text] [Related]
18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
19. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice.
Chastagner P; Kozin SV; Taghian A
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):777-82. PubMed ID: 11395247
[TBL] [Abstract][Full Text] [Related]
20. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]